- Home
- DMN vs SPRC Comparison
DMN vs SPRC Comparison
Compare DMN & SPRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMN
- SPRC
- Stock Information
- Founded
- DMN 2020
- SPRC 2004
- Country
- DMN Canada
- SPRC Israel
- Employees
- DMN N/A
- SPRC N/A
- Industry
- DMN
- SPRC Biotechnology: Pharmaceutical Preparations
- Sector
- DMN
- SPRC Health Care
- Exchange
- DMN NYSE
- SPRC Nasdaq
- Market Cap
- DMN 3.0M
- SPRC 3.1M
- IPO Year
- DMN N/A
- SPRC N/A
- Fundamental
- Price
- DMN $0.01
- SPRC $0.32
- Analyst Decision
- DMN
- SPRC
- Analyst Count
- DMN 0
- SPRC 0
- Target Price
- DMN N/A
- SPRC N/A
- AVG Volume (30 Days)
- DMN 749.8M
- SPRC 5.9M
- Earning Date
- DMN 05-27-2025
- SPRC 02-15-2025
- Dividend Yield
- DMN N/A
- SPRC N/A
- EPS Growth
- DMN N/A
- SPRC N/A
- EPS
- DMN 0.09
- SPRC N/A
- Revenue
- DMN $49,523.00
- SPRC $1,306,000.00
- Revenue This Year
- DMN N/A
- SPRC N/A
- Revenue Next Year
- DMN N/A
- SPRC N/A
- P/E Ratio
- DMN $0.08
- SPRC N/A
- Revenue Growth
- DMN N/A
- SPRC N/A
- 52 Week Low
- DMN $0.00
- SPRC $0.20
- 52 Week High
- DMN $4.95
- SPRC $1.79
- Technical
- Relative Strength Index (RSI)
- DMN N/A
- SPRC 50.23
- Support Level
- DMN N/A
- SPRC $0.30
- Resistance Level
- DMN N/A
- SPRC $0.38
- Average True Range (ATR)
- DMN 0.00
- SPRC 0.04
- MACD
- DMN 0.00
- SPRC 0.00
- Stochastic Oscillator
- DMN 0.00
- SPRC 25.77
About DMN DAMON INC
Damon Inc is a motorcycle manufacturing company that aims to transform the motorcycle industry by building a smart and technologically advanced motorcycle. Damon is developing technology and investing in capabilities to lead the industry in the transformation of the high-performance electric motorcycle market. It is introducing existing enthusiasts to high-performance electric products while bringing new riders to the motorcycle community with first-of-its-kind advances in zero-emissions motorcycle performance, safety, connectivity and AI.
About SPRC SciSparc Ltd.
SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company's operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.